Iovance Biotherapeutics to present at upcoming conferences
Iovance Biotherapeutics announced that senior leadership will present at upcoming conferences.
SAN CARLOS, Calif., Sept.
04, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc.
NASDAQ:IOVA, a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that senior leadership…